Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer

NCT02393703 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT02393703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02393703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Observational
Overall status
Recruiting
Start date
March 31, 2015
Completion date
March 31, 2027
Enrollment
181 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign pancreatic disease, pancreatic cancer